SCHEMBL6205960

SCHEMBL6205960

CCCCCc1ccc(-c2ccc(S(=O)(=O)C3(C(=O)OC(=O)C(F)(F)F)CCOCC3)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 9/20 0.43
MMP9 P14780 7/20 0.43
MMP1 P03956 3/20 0.43
ADAM17 P78536 1/20 0.43
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 4/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
MMP2 P08253 8/20 0.39
MMP8 P22894 8/20 0.39
MMP3 P08254 7/20 0.39
MMP7 P09237 3/20 0.39
MAPT P10636 3/20 0.39
STAT3 P40763 1/20 0.39
ATM Q13315 1/20 0.39
CASP3 P42574 2/20 0.38
SENP8 Q96LD8 2/20 0.38
SENP7 Q9BQF6 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6205958 0.88 RAB9A (0.46) MMP13MMP9MMP1ADAM17RAB9A
SCHEMBL6206622 0.87 MMP13 (0.45) MMP13MMP9MMP1ADAM17RAB9A
SCHEMBL6251227 0.86 RAB9A (0.51) MMP13MMP9MMP1ADAM17RAB9A
SCHEMBL6697955 0.83 MMP13 (0.60) MMP13MMP9MMP1ADAM17RAB9A
SCHEMBL6206244 0.83 MMP13 (0.43) MMP13MMP9MMP1ADAM17MMP2
Hydrochloric Acid SCHEMBL6206733 0.83 MMP13 (0.59) MMP13MMP9MMP1ADAM17RAB9A
SCHEMBL6228589 0.80 MMP13 (0.42) MMP13MMP9MMP1ADAM17MMP2
SCHEMBL6205696 0.79 CYP3A4 (0.39) MMP13MMP9MMP1ADAM17MMP2
SCHEMBL6207085 0.78 MMP13 (0.43) MMP13MMP9MMP1ADAM17RAB9A
SCHEMBL6206525 0.77 MMP13 (0.38) MMP13MMP9MMP1ADAM17MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565459-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS Pharmacia Corporation (US) 2005-08-24 EP disclosed
US-20040142979-A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors PHARMACIA CORPORATION 2004-07-22 US disclosed
WO-2004048368-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142979-A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors MMP3, MMP13, MMP10 MMP13 2/4885MMP9 7/4885MMP1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.